...long.” Merck has a tau PET imaging agent, and licensed a preclinical anti-tau antibody from Teijin Pharma Ltd....
...Inc. (NYSE:PFE), New York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Rodin Therapeutics Inc., Cambridge, Mass. Teijin Pharma Ltd....

...Mass.). Decibel also promoted Paula Cobb to COO from EVP of corporate development. Pharmaceutical company Teijin Pharma Ltd....

...Takeda has rights to the non-purine selective inhibitor of xanthine oxidase from Teijin Pharma Ltd. (Tokyo, Japan). Teijin Pharma Ltd....

...in preclinical development for oncology. Gossamer gained GB001 through the acquisition of Pulmagen Therapeutics Ltd. Teijin Pharma Ltd....

...off 11%. Radius has exclusive, ex-Japanese rights to the product from Ipsen Group (Euronext:IPN; Pink:IPSEY). Teijin Pharma Ltd....
...France Portola Pharmaceuticals Inc. (NASDAQ:PTLA), South San Francisco, Calif. Radius Health Inc. (NASDAQ:RDUS), Waltham, Mass. Teijin Pharma Ltd....

...2017 ). Radius has exclusive, ex-Japanese rights to the product from Ipsen Group (Euronext:IPN; Pink:IPSEY). Teijin Pharma Ltd....
...19, 2005 ). Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Radius Health Inc. (NASDAQ:RDUS), Waltham, Mass. Teijin Pharma Ltd....
...formerly BA058 Injection) Business: Musculoskeletal Allison Johnson Tymlos (BA058-SC, ITM-058, abaloparatide-sc, ba058 injection, eladynos, BIM44058) Ipsen Group Radius Health Inc. Teijin Pharma Ltd. Parathyroid...

...early internal candidates. The product is a beta-site APP-cleaving enzyme 1 (BACE1) inhibitor. Last year, Teijin Pharma Ltd....
...CSF) total tau Status: Phase III discontinued Milestone: NA Jaime De Leon MK-8931 SCH 900931 Bionomics Ltd. Merck & Co. Inc. Teijin Pharma Ltd. Beta-site...

...early internal candidates. The product is a beta-site APP-cleaving enzyme 1 (BACE1) inhibitor. Last year, Teijin Pharma Ltd....
...an undisclosed candidate for cognitive dysfunction associated with AD. Jaime De Leon MK-8931 SCH 900931 verubecestat Bionomics Ltd. Merck & Co. Inc. Teijin Pharma Ltd. Microtubule-associated...

...COO. He was CEO and chief technology officer at Edinburgh Molecular Imaging Ltd. (Edinburgh, U.K.). Teijin Pharma Ltd....

...and neuroendocrine tumors in 70 countries, and is marketed outside the U.S. as Somatuline Autogel. Teijin Pharma Ltd....
...development and marketing deal for the compound in Japan. Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Teijin Pharma Ltd....
...Japan Product: Somatuline Autogel (Somatuline Depot) lanreotide acetate (ITM-014) Business: Cancer Jennie Walters ITM-014 lanreotide acetate Somatuline Autogel Somatuline Depot Ipsen Group Teijin Pharma Ltd. Somatostatin...